The Care Quality Commission’s 2024 annual report on controlled drugs reveals alarming trends in controlled drug misuse across the UK healthcare system. With over 74 million controlled drug items prescribed by NHS primary care services alone, alongside catastrophic prison conditions exposed by HM Chief Inspector of Prisons, the evidence demands immediate prevention-focused intervention to address this escalating crisis affecting every level of British society.

Prison Drug Crisis Undermines National Security

HM Chief Inspector of Prisons has exposed a catastrophic controlled drug misuse epidemic across England and Wales in his latest annual report. Chief Inspector Charlie Taylor’s damning assessment reveals that “the overwhelming ingress of illegal drugs is destabilising prisons” and preventing the essential rehabilitative work needed to reduce reoffending. His team drew from 83 inspection reports published between April 2024 and March 2025, painting an alarming picture of institutional failure.

The evidence of widespread substance abuse within prisons is staggering and unprecedented. In prisoner surveys, 39% of adult male prisoners reported it was easy to obtain illicit drugs, with the figure rising to 58% in category B training prisons. Random mandatory drug testing frequently showed positive rates exceeding 30%, with some prisons recording rates as high as 59%.

At Hindley prison, a category C establishment, inspectors discovered that in the six months before their review visit, an astounding 59% of randomly selected prisoners tested positive for illicit drug use. In April 2024, this rate reached a shocking 77%. The situation had deteriorated so severely that inspectors found more prisoners under the influence of drugs than sober – a first in the Chief Inspector’s experience.

The correlation between drug availability and violence is unmistakable. Nationally, assaults on staff increased by 13% compared to the previous year, whilst prisoner-on-prisoner violence rose by 10%. At Manchester prison, serious assaults reached the highest rate of all adult male prisons, directly linked to the drug economy and associated debt problems.

Sophisticated Criminal Operations Target UK Prisons

Organised crime groups deploy advanced drone technology that delivers substantial quantities of contraband within 20 seconds, making interception extremely difficult. These criminal organisations make calculated investments – the drones cost thousands of pounds and represent sophisticated operations targeting the heart of the justice system.

At Manchester and Long Lartin prisons, which house some of Britain’s most dangerous offenders including terrorists and organised crime bosses, criminal gangs conducted regular drone deliveries with impunity. Prison authorities allowed physical security to deteriorate catastrophically: they left protective netting inadequate, compromised windows, and allowed CCTV systems to fall into disrepair. At Manchester, prisoners actually burned holes in supposedly secure windows to facilitate regular deliveries.

The security failures extend beyond physical infrastructure. Staff corruption has reached alarming levels, with organised crime groups embedding “sleeper” agents within the prison service – individuals with clean criminal records who apply for prison officer positions, become established, and then begin smuggling operations once they understand security weaknesses. At Manchester, inexperienced staff were being systematically manipulated or simply ignored by prisoners, often retreating to wing offices and leaving prisoners effectively unsupervised.

Urgent Notification Crisis Exposes System Collapse

The Chief Inspector issued four Urgent Notification letters – the strongest action available to highlight immediate dangers – demonstrating the severity of the controlled drug misuse crisis. Drugs played a central role in each case: Wandsworth, Rochester, Manchester, and Winchester all received these emergency interventions.

At Wandsworth, still reeling from a high-profile escape in 2023, the regime had descended into chaos. Staff could not account for prisoners, cannabis smell was ubiquitous throughout the facility, and there had been 10 self-inflicted deaths since the last inspection. The prison experienced a 50% increase in violence against staff, with 69% of prisoners reporting feeling unsafe.

Rochester, a category C training prison, saw less than a third of its population engaged in purposeful activity, with illicit drug use endemic throughout the facility. The prison attracted the lowest healthy prison assessment in three of four tests, with many recommendations from the 2021 inspection still unaddressed.

Winchester presented perhaps the most dangerous environment, with violence rates among the highest in the country and serious assaults against staff and prisoners reaching unprecedented levels. Many prisoners lived in appalling conditions without access to meaningful activities, whilst the prison systematically failed to address concerns raised in the 2022 inspection.

Manchester showed a concerning decline across three of four healthy prison tests, with organised criminal activity, serious violence, widespread drug use, and staff lacking confidence creating an unstable and filthy environment. The prison was failing in its function as a training facility, with very poor delivery of education, training, and work programmes.

Living Conditions Fuel Controlled Drug Misuse

Prison living conditions directly contribute to the controlled drug misuse epidemic. Overcrowding persists, particularly in reception prisons where prisoners share cells originally designed for one person. These cramped conditions offer inadequate decency, with some cells lacking screening around toilets and providing only one chair for two occupants.

Much of the prison estate suffers from chronic underinvestment. Broken furniture, damaged windows, and vermin infestations are commonplace. At Manchester, food thrown from cell windows exacerbated rat problems. At Rochester, prisoners installed makeshift barriers under cell doors to prevent rodent entry. Some older wings at Long Lartin lack in-cell toilets, leading to bags of human excrement being thrown from windows.

Time out of cell remains inadequate across the estate. In reception prisons, 54% of prisoners reported spending less than two hours outside their cells each weekday. At Winchester, Hull, and Nottingham, unemployed prisoners spent at least 21 hours daily locked up. Weekend conditions were particularly poor, with a third of prisoners spending less than two hours unlocked on Saturdays and Sundays.

Healthcare System: 74 Million Prescriptions Fuel Crisis

Beyond prison walls, the controlled drug misuse crisis extends throughout the healthcare system. The CQC’s 2024 report reveals that NHS primary care services prescribed 74,160,671 controlled drug items – a slight increase from 73,851,955 items in 2023. The financial cost reached £585.6 million, representing a 2% increase from the previous year.

The breakdown by schedule reveals concerning patterns:

• Schedule 2 (13%): 9,514,472 items including strong opioids and stimulants
• Schedule 3 (36%): 26,551,610 items including moderate-strength drugs
• Schedule 4 (17%): 12,450,327 items including benzodiazepines
• Schedule 5 (35%): 25,644,262 items including weak opioids

Particularly concerning is the dramatic surge in ADHD medication prescribing. Dexamfetamine prescriptions increased by 50% to 169,467 items, lisdexamfetamine by 27% to 630,949 items, and methylphenidate by 7% to 1,643,120 items. These Schedule 2 controlled drugs carry significant abuse potential and require stringent oversight.

ADHD Medication Crisis Reaches Breaking Point

The explosion in ADHD medication prescribing represents a critical aspect of the controlled drug misuse crisis. Adult prescribing has risen steeply since 2019, with particularly sharp increases in dexamfetamine and lisdexamfetamine. The sustained increase has become more pronounced since 2020, with all three medicines showing relatively sharp upward trends compared to other controlled drugs.

Private prescribing shows even more alarming patterns. Independent primary care services prescribed 540,227 controlled drug items in 2024 – a 38% increase from 390,788 items in 2023. This surge is primarily driven by ADHD medications, with Schedule 2 drugs accounting for 97% of all private prescribing.

The breakdown of private Schedule 2 prescribing reveals:

• Methylphenidate: 259,528 items (40% increase)
• Lisdexamfetamine: 206,206 items (36% increase)
• Dexamfetamine: 52,758 items (58% increase)

These increases raise serious concerns about capacity in NHS settings, the proliferation of independent clinics including online services, and inadequate shared care arrangements between private and NHS providers.

Non-Medical Prescribing Expansion Creates New Risks

The growth in non-medical prescribing presents another dimension of controlled drug misuse risk. Overall prescribing by healthcare professionals other than doctors or dentists increased by 9% to 5,922,526 items in 2024. This trend is expected to continue as pharmacists graduating in 2025 will all qualify as prescribers.

Pharmacists undertook 56% of all non-medical prescribing (3,332,074 items), showing a 15% increase from 2023. Their prescribing of ADHD medications increased dramatically:

• Lisdexamfetamine: 42% increase to 36,389 items
• Methylphenidate: 42% increase to 82,181 items
• Dexamfetamine: 65% increase to 9,947 items

Nurse prescribing remained stable at 2,545,702 items, whilst paramedic prescribing exploded by 704% to 41,154 items following legal changes permitting them to prescribe specific controlled drugs. However, prescribing data shows paramedics continue prescribing beyond their legal scope, with 1,176 zopiclone prescriptions issued despite lacking authority.

Geographic variations reveal concerning patterns, with non-medical prescribing highest in the North East and Yorkshire and lowest in the East of England, suggesting inconsistent access and oversight.

Cannabis-Based Products Drive Prescription Explosion

The prescribing of cannabis-based products for medicinal use (CBPMs) represents perhaps the most dramatic aspect of controlled drug misuse expansion. Private unlicensed CBPM prescriptions exploded by 130% between March 2023 and March 2024, rising from 150,527 items to 346,600 items.

At the time of publication, 35 providers prescribing unlicensed CBPMs were registered with CQC. Almost all prescribing continues in the independent sector, with NHS prescribing numbers so small they cannot be published due to patient confidentiality concerns.

The CQC identified multiple serious concerns with CBPM prescribing:

Scope of Practice Issues: The majority of non-medical CBPM prescribing involves pharmacist prescribers who must work within their professional scope. Medical specialists must retain oversight of patient care and prescribing, but services often fail to ensure specialists have adequate time for their duties.

Unmet Clinical Need: Services prescribe for very wide ranges of medical conditions, many with poor evidence justifying CBPM use. Some services suggest patients need only two previous failed treatments to qualify, but providers must demonstrate genuine unmet clinical need for each individual case.

Inadequate Peer Review: Smaller providers often lack appropriate specialist teams for effective peer review. Multi-disciplinary teams must comprise specialists relevant to the conditions being treated – a gastroenterologist cannot appropriately review complex epilepsy cases.

Communication Failures: Providers frequently fail to communicate treatment plans timely with other healthcare professionals, particularly GPs. This creates dangerous gaps in patient safety oversight and coordination of care.

CQC Oversight Infrastructure Under Pressure

The CQC maintains a register of approximately 1,000 Controlled Drug Accountable Officers (CDAOs) across England, approving 16 exemption requests during 2024. These designated bodies face legal requirements to notify the CQC of CDAO changes, yet many fail to maintain updated contact details on the published register.

NHS England regional CDAOs establish and lead Local Intelligence Networks (LINs) in their geographical areas, holding at least two meetings annually. These networks discuss controlled drug incidents, share learning, and connect intelligence to identify issues early. However, upcoming NHS England integration into the Department of Health and Social Care threatens this crucial function.

The CQC warns that where CDAO roles are split or shared with other responsibilities – such as chief pharmacist or medical director roles – controlled drugs often fail to receive appropriate focus due to workload pressures. The 2006 experience, when the national controlled drugs function was spread across primary care trusts, demonstrated how diluted functions become less effective at identifying, sharing, and acting on incidents.

Healthcare Fraud and Diversion Schemes

Controlled drug misuse extends beyond legitimate prescribing into sophisticated fraud and diversion schemes. The CQC documented numerous cases throughout 2024:

Professional Impersonation: Cases involved people impersonating pharmacists, doctors, and other healthcare professionals. Criminals use publicly available professional registers to claim legitimacy and gain employment, highlighting vulnerabilities in recruitment processes.

Medication Switching: Sophisticated diversion schemes involve emptying controlled drug blister packs and replacing contents with different tablets of similar appearance. Liquid preparations are diverted and “topped up” with other substances to maintain volume and avoid detection.

Electronic System Fraud: Criminals exploit electronic prescribing systems by generating prescriptions, deleting them, then requesting “re-prints.” This extends beyond healthcare professionals to support staff such as prescription clerks in GP surgeries.

Sharps Bin Theft: Used sharps bins are stolen to extract part-used controlled drugs disposed within them. Organisations must ensure bins are managed and secured promptly to prevent this exploitation.

Self-Prescribing: Healthcare professionals inappropriately prescribe controlled drugs for personal use or for people known to them, violating professional standards and creating diversion opportunities.

Home Office Licensing Creates Access Barriers

Home Office controlled drug licensing presents significant barriers to legitimate healthcare provision whilst potentially creating controlled drug misuse opportunities. Current waiting times can reach 12 months from application to licence approval, forcing services to operate without proper authorisation or delay essential patient care.

Care homes face particular challenges providing end-of-life care without controlled drug stocks. Many are unaware of potential exemptions if 50% of their funding comes from charity or public sources. Others cannot assure themselves they meet exemption requirements. This creates inefficient workarounds, increased costs, and potential diversion opportunities when each patient requires individual named supplies.

The requirement for “wet signatures” on controlled drug prescriptions for hospitals and prison services causes logistical problems, especially for services operating across large geographical areas. This outdated requirement delays discharges and supply despite many services having secure, auditable electronic systems with superior safety measures.

Prevention of Future Deaths Reveals Systemic Failures

Coroners’ Prevention of Future Death Reports highlight recurring themes contributing to controlled drug misuse and related fatalities:

Communication Failures: Inadequate information sharing between healthcare providers regarding medication changes, patient histories, and drug-associated risks. Critical medicines information fails to transfer across care settings, creating significant patient safety risks.

Inappropriate Assumptions: Healthcare professionals assuming drug-seeking behaviour without thorough patient history review has resulted in inadequate disease management, delayed treatment, and unnecessary suffering. Some cases led to self-harm or suicide when legitimate medical needs were dismissed.

Poor Pain Management: Patients have died after taking extreme measures to manage inadequately treated pain, including doubling prescribed doses without clinical guidance. Structured care with regular reviews and comprehensive pain management plans are essential to prevent unsafe self-medication.

Prescribing and Dispensing Failures: Duplicate prescriptions and oversupply went undetected due to lack of real-time communication and flagging mechanisms. Patients with opioid misuse histories exploited these gaps to acquire excessive quantities from multiple sources.

Dangerous Polypharmacy: Multiple central nervous system depressants prescribed to patients already receiving opioids led to respiratory depression and fatal overdoses. Lack of medication reviews and failure to consider drug interactions contributed to preventable deaths.

Regulatory and Legislative Barriers Hinder Prevention

Outdated legislation creates barriers to effective controlled drug misuse prevention. The Advisory Council on the Misuse of Drugs recommended electronic prescribing for hospitals and prison services in 2023, but implementation has not occurred. Services with secure, auditable systems superior to paper processes cannot utilise them due to legislative constraints.

The CQC’s National Overprescribing Review led to development of the first national repeat prescribing toolkit in 20 years, addressing the finding that regular medication reviews for long-term patients often fail to occur promptly. This toolkit represents significant progress, but implementation across all services remains incomplete.

Nitazenes – synthetic opioids with no clinical value – continue appearing in counterfeit medicines, requiring staff awareness through National Patient Safety Alerts. Similarly, xylazine classification as a Class C drug reflects its increasing illicit use in combination with opioids and presence in cannabis vapes.

NHS Pharmacy First Service Oversight Concerns

The NHS Pharmacy First service, designed to reduce pressure on primary and urgent care services, shows concerning patterns in controlled drug misuse potential. Most controlled drugs supplied were Schedule 5 substances, but pharmacists frequently supplied quantities exceeding five-day requirements. This pattern was highlighted across many Controlled Drug Local Area Networks during 2024.

The service supplied various controlled drugs including co-codamol, codeine, clobazam, clonazepam, diazepam, dihydrocodeine, morphine sulfate, testosterone, and zopiclone. Whilst serving legitimate access needs, inadequate quantity controls create diversion opportunities and potential dependence risks.

Successful Prevention Models Demonstrate Solutions

Despite overwhelming challenges, some institutions demonstrate that controlled drug misuse can be effectively prevented through comprehensive approaches:

Prison Success Stories: Cardiff developed an effective, regularly monitored drug strategy achieving measurable reduction. Humber managed significant supply reduction through strong leadership and partnership working. Oakwood, rated the best prison of its type, created environments where nearly all prisoners engaged meaningfully with significantly better time out of cell.

Healthcare Prevention: Some services implemented drug testing schemes in 2024 with positive outcomes, enabling staff to access support earlier when diversion and addiction were detected. These schemes contributed to patient safety whilst supporting healthcare worker wellbeing.

Governance Improvements: More organisations now conduct regular audit and monitoring checks, though governance processes remain lacking in many services. Electronic controlled drug registers and medicines storage systems show benefits, though implementation challenges persist.

National Security and Economic Implications

Chief Inspector Taylor emphasised that the situation has become “a threat to national security.” When high-security prisons housing terrorists and organised crime bosses cannot maintain basic security, implications extend far beyond individual cases. The police and prison service have effectively “ceded the airspace above two high-security prisons to organised crime gangs.”

The economic impact remains unmeasured. No published cost estimation exists for annual controlled drug diversion in the UK, though 2013 government statistics showed organised crime cost £24 billion annually. Better diversion data would ensure appropriate national resource allocation for prevention efforts.

Early release schemes, whilst necessary for overcrowding, created additional pressures. The SDS40 scheme released 3,112 prisoners in just two days, overwhelming offender management units and potentially compromising oversight of individuals with substance abuse histories.

Technology Solutions and Electronic Systems

Electronic systems offer both solutions and vulnerabilities in controlled drug misuse prevention. Artificial intelligence is increasingly common, but the CQC warns against AI meeting recording software in Local Intelligence Network meetings, which must remain safe spaces for frank discussion of concerns and incidents.

The NHS England Controlled Drug Reporting Tool provides standardised platforms for incident reporting and includes learning videos on governance topics. However, electronic systems also create new fraud opportunities requiring robust access controls and audit capabilities.

Electronic prescribing, where legally permitted, offers superior safety measures compared to paper systems. The delay in implementing electronic prescribing recommendations represents a missed opportunity for enhanced prevention measures.

The Path Forward: Comprehensive Prevention Strategy

The evidence demands a comprehensive, coordinated prevention strategy addressing controlled drug misuse across all sectors. Investment in advanced security technology is essential, but equally important is addressing demand through meaningful activities, proper staffing levels, and robust governance systems.

Healthcare providers must strengthen prescribing oversight, enhance communication between services, and implement fail-safe mechanisms preventing diversion. Professional training programmes should emphasise prevention strategies and early identification of problematic prescribing patterns.

Prison services require immediate security upgrades, staff training, and meaningful activity programmes addressing the boredom and frustration driving drug demand. Coordination between prison services, police, and security agencies must treat organised crime infiltration as the national security threat it represents.

Legislative reform should prioritise electronic prescribing implementation, streamline Home Office licensing for legitimate providers, and remove barriers preventing effective end-of-life care in community settings.

Only through coordinated prevention action across all sectors can the controlled drug misuse epidemic be effectively addressed. The current situation threatens individual health outcomes, public safety, rehabilitation prospects, and national security. Without decisive intervention, both healthcare services and criminal justice systems will continue failing in their fundamental duty to protect society through effective substance abuse prevention.

The time for incremental responses has passed. The scale and sophistication of controlled drug misuse demand comprehensive prevention strategies implemented with the urgency this national crisis deserves.

Source: dbrecoveryresources